Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Reproductive Tract Infections D060737 1 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Pneumonia, Lipid D011017 2 associated lipids
Protozoan Infections D011528 6 associated lipids
Tick Bites D064927 1 associated lipids
Granulomatous Mastitis D058890 1 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Kurdowska A et al. The effect of azithromycin and clarithromycin on ex vivo interleukin-8 (IL-8) release from whole blood and IL-8 production by human alveolar macrophages. 2001 J. Antimicrob. Chemother. pmid:11389120
Chokephaibulkit K et al. Intestinal parasitic infections among human immunodeficiency virus-infected and -uninfected children hospitalized with diarrhea in Bangkok, Thailand. 2001 Southeast Asian J. Trop. Med. Public Health pmid:12041552
Solera J et al. Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. 2001 Clin. Infect. Dis. pmid:11170962
Ioannidis JP et al. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. 2001 J. Antimicrob. Chemother. pmid:11679557
Contopoulos-Ioannidis DG et al. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections. 2001 J. Antimicrob. Chemother. pmid:11679558
Laurent J et al. A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. 2001 Aliment. Pharmacol. Ther. pmid:11683693
Damianov L et al. [Treatment of genital chlamydia infections with Sumamed]. 2001 Akush Ginekol (Sofiia) pmid:11519320
Doern GV Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. 2001 Clin. Infect. Dis. pmid:11524718
Castor D et al. Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago. 2001 Cell. Mol. Biol. (Noisy-le-grand) pmid:11785665
van der Griend B et al. An uncommon cause of a destructive vulval lesion. 2001 Aust N Z J Obstet Gynaecol pmid:11787928
Holm SO et al. Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. 2001 Bull. World Health Organ. pmid:11285662
Frick KD et al. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. 2001 Bull. World Health Organ. pmid:11285663
Bailey R and Lietman T The SAFE strategy for the elimination of trachoma by 2020: will it work? 2001 Bull. World Health Organ. pmid:11285668
Chetchotisakd P et al. Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline. 2001 Jan-Feb Am. J. Trop. Med. Hyg. pmid:11425157
Baumann U et al. Buccal adherence of Pseudomonas aeruginosa in patients with cystic fibrosis under long-term therapy with azithromycin. 2001 Jan-Feb Infection pmid:11261763
Kent JR et al. Azithromycin: an assessment of its pharmacokinetics and therapeutic potential in CAPD. 2001 Jul-Aug Perit Dial Int pmid:11587400
Gakiya E et al. [Experimental infection in mice by Plasmodium berghei: an evidence of antiparasitic action of azithromycin]. 2001 Mar-Apr Rev. Soc. Bras. Med. Trop. pmid:11391444
Lorenz J et al. Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective. 2001 Mar-Apr J. Int. Med. Res. pmid:11393351
Postma MJ et al. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis. 2001 May-Jun Value Health pmid:11705188
Akritopoulou-Zanze I and Sowin TJ Solid-phase synthesis of macrolide analogues. 2001 May-Jun J Comb Chem pmid:11350254
Aberg JA et al. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis. 2001 Nov-Dec HIV Clin Trials pmid:11742432
Biswas S In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum. 2001 Oct-Dec J Postgrad Med pmid:11832638
Pukrittayakamee S et al. Therapeutic responses to antibacterial drugs in vivax malaria. 2001 Sep-Oct Trans. R. Soc. Trop. Med. Hyg. pmid:11706666
Schilling F and Kessler S [Chronic recurrent multifocal osteomyelitis-- I. Review]. 2001 Sep-Oct Klin Padiatr pmid:11582525
Schilling F et al. [Pelvic type of chronic recurrent multifocal osteomyelitis]. 2001 Sep-Oct Klin Padiatr pmid:11582526
Dubois J and St-Pierre C In vitro susceptibility study of BMS-284756 against Legionella species. 2001 Sep-Oct Diagn. Microbiol. Infect. Dis. pmid:11687318
[Antibiotics in routine practice. With proper selection rapid success]. 2002 MMW Fortschr Med pmid:12532526
Bogomil'skiÄ­ MP and Komarov RM [Azithromycin in the treatment of acute otitis media]. 2002 Antibiot. Khimioter. pmid:12515096
Hand WI and Hand DL [Mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes]. 2002 Antibiot. Khimioter. pmid:12516190
Di Paolo A et al. Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily. 2002 Pharmacol. Res. pmid:12457629
Chiu LM et al. Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers. 2002 J. Antimicrob. Chemother. pmid:12461037
Hauke W et al. Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study. 2002 Chemotherapy pmid:12476043
Kamau FN et al. Isocratic liquid chromatographic method for the analysis of azithromycin and its structurally related substances in bulk samples. 2002 J Chromatogr Sci pmid:12433117
Tyteca D et al. Azithromycin, a lysosomotropic antibiotic, has distinct effects on fluid-phase and receptor-mediated endocytosis, but does not impair phagocytosis in J774 macrophages. 2002 Exp. Cell Res. pmid:12441132
Aguirrebengoa K et al. [Endocarditis due to Bartonella henselae on a native valve. A new case with some notable aspects]. 2002 Enferm. Infecc. Microbiol. Clin. pmid:12372243
Ivashkin VT et al. Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. 2002 World J. Gastroenterol. pmid:12378634
House D et al. Cytokine release by lipopolysaccharide-stimulated whole blood from patients with typhoid fever. 2002 J. Infect. Dis. pmid:12134261
Wallace Jr RJ et al. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis. 2002 J. Infect. Dis. pmid:12134265
Cheng H et al. Synthesis and SAR of azalide 3,6-ketal aromatic derivatives as potent Gram-positive and Gram-negative antibacterial agents. 2002 Bioorg. Med. Chem. Lett. pmid:12161150
Kawashima M et al. Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury. 2002 Lung pmid:12182159
Yee CL et al. Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin. 2002 Pediatr. Infect. Dis. J. pmid:12182376
Clark C et al. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. 2002 Antimicrob. Agents Chemother. pmid:12183253
Blandizzi C et al. Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients. 2002 Antimicrob. Agents Chemother. pmid:11959610
Ekici A et al. Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. 2002 J Asthma pmid:11990233
Mohler AM Treatment of streptococcal pharyngitis. 2002 Am Fam Physician pmid:11996411
Davis JL et al. Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. 2002 J. Vet. Pharmacol. Ther. pmid:12000529
Ng LK et al. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. 2002 Antimicrob. Agents Chemother. pmid:12183262
Mandell GL and Coleman EJ Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorphonuclear leukocytes. 2002 J. Infect. Dis. pmid:12001049
Prunier AL et al. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. 2002 Antimicrob. Agents Chemother. pmid:12183270
Treadway G et al. The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections. 2002 Int. J. Antimicrob. Agents pmid:11932140
[Unfortunately without effectiveness: chlamydia eradication after infarct]. 2002 MMW Fortschr Med pmid:12014269
Suriawinata A and Min AD A 33-year-old woman with jaundice after azithromycin use. 2002 Semin. Liver Dis. pmid:12016551
Evans AT et al. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. 2002 Lancet pmid:12020525
King A et al. Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. 2002 Clin. Microbiol. Infect. pmid:11952721
Lisby JG et al. [Bacteremia and meningitis caused by Streptococcus pneumoniae during treatment with azithromycin]. 2002 Ugeskr. Laeg. pmid:12043408
Nishikawa T [Comment on the contribution by Weigl CB et al. "Papillomatosis confluens et reticularis"]. 2002 Hautarzt pmid:12063751
Batieha A et al. No advantage of treating acute respiratory tract infections with azithromycin in a placebo-controlled study. 2002 Scand. J. Infect. Dis. pmid:12064684
Carryn S et al. Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. 2002 Antimicrob. Agents Chemother. pmid:12069960
Babl FE et al. Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo. 2002 Antimicrob. Agents Chemother. pmid:12069974
Chimura T [Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field]. 2002 Jpn J Antibiot pmid:12071097
Reshetniak VI et al. [Eradication of Helicobacter pylori in patients with duodenal ulcer following the short course of treatment with azitromycin and amoxycillin]. 2002 Antibiot. Khimioter. pmid:12087718
Kays MB et al. Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation. 2002 Diagn. Microbiol. Infect. Dis. pmid:12088625
Breier AR et al. Microbiological assay for azithromycin in pharmaceutical formulations. 2002 J Pharm Biomed Anal pmid:12093530
Muirhead GJ et al. The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers. 2002 Br J Clin Pharmacol pmid:11879258
Gomberg MA [Combined treatment of persisting urogenital chlamydia infection with sumamed and interferon alfa]. 2002 Antibiot. Khimioter. pmid:12365322
Hammerschlag MR Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. 2002 Circulation pmid:12370232
Adimora AA Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. 2002 Clin. Infect. Dis. pmid:12353204
Augenbraun MH Treatment of syphilis 2001: nonpregnant adults. 2002 Clin. Infect. Dis. pmid:12353205
Itoh M et al. [A case of immotile-dyskinetic cilia syndrome responding to clenbuterol hydrochloride and azithromycin]. 2002 Nihon Kokyuki Gakkai Zasshi pmid:12382429
Equi A et al. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. 2002 Lancet pmid:12383667
Krolewiecki A et al. Activity of azithromycin against Leishmania major in vitro and in vivo. 2002 Am. J. Trop. Med. Hyg. pmid:12408666
Neumann FJ Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance. 2002 Circulation pmid:12417534
Skerk V et al. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. 2002 J Chemother pmid:12420857
Sieper J and Braun J [Diagnosis and antibiotic treatment of reactive arthritis]. 2002 Dtsch. Med. Wochenschr. pmid:12226789
Chandrupatla S et al. Azithromycin-induced intrahepatic cholestasis. 2002 Dig. Dis. Sci. pmid:12395890
Nagai K et al. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. 2002 Antimicrob. Agents Chemother. pmid:11796375
Duff P Antibiotic selection in obstetrics: making cost-effective choices. 2002 Clin Obstet Gynecol pmid:11862059
Wolter J et al. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. 2002 Thorax pmid:11867823
Zhou F et al. High accuracy mass measurement of peptides with internal calibration using a dual electrospray ionization sprayer system for protein identification. 2002 Rapid Commun. Mass Spectrom. pmid:11870887
Krudsood S et al. A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. 2002 Southeast Asian J. Trop. Med. Public Health pmid:12693587
Burton MJ et al. Azithromycin for the treatment and control of trachoma. 2002 Expert Opin Pharmacother pmid:11829725
Ohara T et al. [Protective effect of azithromycin against verotoxin]. 2002 Kansenshogaku Zasshi pmid:11905000
Salaria M and Singh M Atypical pneumonia in children. 2002 Indian Pediatr pmid:11910135
Desta Z et al. In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin. 2002 J Clin Psychopharmacol pmid:11910261
Ito N and Kudo S [Case of polycystic lung disease with mixed infections due to Aspergillus and Mycobacterium fortuitum successfully treated by AZM]. 2002 Jpn J Antibiot pmid:12664928
Kim MK et al. Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model. 2002 Antimicrob. Agents Chemother. pmid:12234843
Smith SR et al. A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results. 2002 J. Clin. Periodontol. pmid:11846850
Wu ML et al. Enterocolonic Mycobacterium avium-intracellulare. 2002 Arch. Pathol. Lab. Med. pmid:11860323
Cascio A et al. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. 2002 Clin. Infect. Dis. pmid:11740701
Schachter J and Dawson CR Elimination of blinding trachoma. 2002 Curr. Opin. Infect. Dis. pmid:12686881
Kutlin A et al. Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model. 2002 Antimicrob. Agents Chemother. pmid:11796350
Strle F and Maraspin V Is azithromycin treatment associated with prolongation of the Q-Tc interval? 2002 Wien. Klin. Wochenschr. pmid:12708094
Dawson CR and Schachter J Should trachoma be treated with antibiotics? 2002 Lancet pmid:11812548
Zubata P et al. A new HPLC method for azithromycin quantitation. 2002 J Pharm Biomed Anal pmid:11814725
Lentino JR and Krasnicka B Association between initial empirical therapy and decreased length of stay among veteran patients hospitalized with community acquired pneumonia. 2002 Int. J. Antimicrob. Agents pmid:11814769
Phillips P et al. Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program. 2002 Clin. Infect. Dis. pmid:11774085
Dai G et al. [Researching some sensitivity factor of bioassay method on the antibiotics pharmacokinetics]. 2002 Hunan Yi Ke Da Xue Xue Bao pmid:12575254
Dzelalija B et al. Randomized trial of azithromycin in the prophylaxis of Mediterranean spotted fever. 2002 Acta Med Croatica pmid:12596623
Nalbanski B and Nalbanski A [Treatment of Chlamydia trachomatis with azatril]. 2002 Akush Ginekol (Sofiia) pmid:11935692
Krumov G et al. [Treatment of chlamydial cervicitis with azatril]. 2002 Akush Ginekol (Sofiia) pmid:11935693